{"slideshow_credits": null, "snippet": "The deal would create a specialty pharmaceutical company that would be one of the five largest generic drug makers based on sales in the United States.", "abstract": null, "section_name": "Business Day", "print_page": null, "document_type": "article", "byline": {"person": [{"firstname": "Chad", "role": "reported", "lastname": "BRAY", "rank": 1, "organization": ""}], "original": "By CHAD BRAY"}, "web_url": "http://www.nytimes.com/2015/05/19/business/dealbook/endo-international-to-pay-8-05-billion-for-par-pharmaceutical.html", "lead_paragraph": "The deal would create a specialty pharmaceutical company that would be one of the five largest generic drug makers based on sales in the United States.", "headline": {"main": "Endo International to Pay $8.05 Billion for Par Pharmaceutical", "print_headline": "Drug Maker Merger Would Create Powerhouse in Generics "}, "_id": "5559d6b638f0d873642285ba", "word_count": "415", "multimedia": [], "pub_date": "2015-05-19T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "1"}, {"name": "subject", "value": "Private Equity", "is_major": "N", "rank": "2"}, {"name": "organizations", "value": "Endo International PLC", "is_major": "N", "rank": "3"}, {"name": "organizations", "value": "TPG Capital", "is_major": "N", "rank": "4"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "5"}, {"name": "subject", "value": "Generic Brands and Products", "is_major": "N", "rank": "6"}, {"name": "subject", "value": "Stocks and Bonds", "is_major": "N", "rank": "7"}, {"name": "glocations", "value": "Dublin (Ireland)", "is_major": "N", "rank": "8"}, {"name": "glocations", "value": "Pennsylvania", "is_major": "N", "rank": "9"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}